⚠️ This provider averages 650 services per working day — physically unusual for an individual practitioner
Based on 1.6M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $24.0M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.
Averaging 650 services per working day raises questions about billing patterns.
Medicare payments to this provider grew 459% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 73% in 2017
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $45.78 | $15.23 | 3.01x | $30.55 | $628.0K | 41.2K | 34 |
| 2015 | $41.49 | $11.29 | 3.67x | $30.20 | $665.9K | 59.0K | 40 |
| 2016 | $39.18 | $13.35 | 2.93x | $25.83 | $1.1M | 79.1K | 45 |
| 2017 | $39.34 | $13.80 | 2.85x | $25.54 | $1.8M | 132.7K | 49 |
| 2018 | $30.26 | $11.04 | 2.74x | $19.22 | $2.1M | 187.6K | 46 |
| 2019 | $36.64 | $13.29 | 2.76x | $23.35 | $3.4M | 255.5K | 49 |
| 2020 | $40.29 | $16.12 | 2.50x | $24.17 | $4.0M | 248.8K | 51 |
| 2021 | $41.20 | $16.42 | 2.51x | $24.78 | $3.2M | 195.7K | 44 |
| 2022 | $49.46 | $16.91 | 2.92x | $32.55 | $3.7M | 217.0K | 51 |
| 2023 | $53.67 | $16.91 | 3.17x | $36.76 | $3.5M | 207.7K | 48 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 117.2K | $4.8M | $41.23 | 1.99x |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 73.9K | $2.9M | $39.37 | 2.06x |
| J0897 | Injection, denosumab, 1 mg | 167.5K | $2.5M | $15.19 | 1.78x |
| J9299 | Injection, nivolumab, 1 mg | 108.6K | $2.2M | $20.65 | 2.07x |
| J2505 | Injection, pegfilgrastim, 6 mg | 521 | $1.7M | $3.2K | 2.52x |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 34.4K | $1.3M | $37.19 | 3.55x |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 19.9K | $740.3K | $37.23 | 3.98x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 6.1K | $704.8K | $114.91 | 3.31x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 7.1K | $647.3K | $91.45 | 2.50x |
| J3380 | Injection, vedolizumab, 1 mg | 38.7K | $599.4K | $15.49 | 1.64x |
| J9310 | Injection, rituximab, 100 mg | 907 | $568.1K | $626.37 | 1.99x |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 193.0K | $543.6K | $2.82 | 4.26x |
| Q5111 | Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | 3.2K | $470.0K | $148.93 | 4.89x |
| J9312 | Injection, rituximab, 10 mg | 6.3K | $466.8K | $73.69 | 1.86x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 6.3K | $372.2K | $59.44 | 2.64x |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 11.1K | $311.7K | $28.00 | 2.79x |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | 1.8K | $233.9K | $131.48 | 2.73x |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 305.5K | $213.3K | $0.70 | 2.96x |
| J1453 | Injection, fosaprepitant, 1 mg | 200.7K | $208.6K | $1.04 | 2.89x |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 3.6K | $207.6K | $56.91 | 3.53x |
This provider submits charges 2.81 times higher than what Medicare actually pays.
A markup ratio of 2.81x means for every $100 Medicare pays, this provider initially charges $281. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Hematology-Oncology providers in IL for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Pramern Sriratana, M.D. | Normal, IL | $33.5M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data